Livedo racemosa, secondary to drug-induced systemic lupus erythematosus

Dermatology Online Journal

Volumn 16, Issue 11, 2010, Pages

  Defelice, Taylor ^a   Lu, Phoebe ^a   Loyd, Aaron ^a   Patel, Rishi ^a   Franks Jr , Andrew G ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; ETIRACETAM; HISTONE ANTIBODY; PHENYTOIN; ACETYLSALICYLIC ACID; AUTOANTIBODY; HISTONE;

ADULT; ARTICLE; BEDTIME DOSAGE; BRAIN INFARCTION; CASE REPORT; CLINICAL SKIN REACTION; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG ERUPTION; ECHOGRAPHY; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; LIVEDO RACEMOSA; LUPUS LIKE SYNDROME; LYMPHOCYTIC INFILTRATION; MALE; PHYSICAL EXAMINATION; SEIZURE; SKIN BIOPSY; BLOOD; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; LIVEDO RETICULARIS; SKIN BLOOD VESSEL DISORDER; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ASPIRIN; AUTOANTIBODIES; HISTONES; HUMANS; LIVEDO RETICULARIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PHENYTOIN; SKIN DISEASES, VASCULAR; SMOKING;

EID: 78650578662     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Marzano AV, et al. Drug-induced lupus: an update on its dermatologic aspects. Lupus 2009;18:935 [PubMed]
2. Grossman L, Barland P. Histone reactivity of drug-induced antinuclear antibodies: a comparison of symptomatic and asymptomatic patients. Arthritis Rheum 1981;24:927 [PubMed]
3. Mor A, et al. Drug-induced arthritic and connective tissue disorders. Semin Arthritis Rheum 2008;38:249 [PubMed]
4. Uthman IW, Khamashta MA. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol 2006;33:2379 [PubMed]
5. McHugh NJ, et al. Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythermatosus. Ann Rheum Dis 1988;47:110 [PubMed]
6. Baguley E, et al. Anticardiolipin antibodies, livedo reticularis, and cerebrovascular accidents in SLE. Ann Rheum Dis 1988;47:702 [PubMed]
7. Frances C, et al. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum 2005;52:1785 [PubMed]
8. Toubi E, et al. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome. Clin Exp Rheumatol 2005;23:499 [PubMed]
9. Sangle SR, et al. Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis 2003;62:999 [PubMed]
10. Sneddon IB. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 1965;77:180 [PubMed]
11. Frances C, Piette JC. The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus. J Autoimmun 2000;15:139 [PubMed]
12. Kraemer M, et al. The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa: a literature review. J Neurol 2005;252:115 [PubMed]
13. Frances C, et al. Sneddon syndrome with or without antiphospholipid antibodies: a comparative study in 46 patients. Medicine (Baltimore) 199;78:209 [PubMed]
14. Zelger B, et al. Life history of cutaneous vascular lesions in Sneddon's syndrome. Hum Pathol 1992;23:668
15. Wohlrab J, et al. Diagnostic impact and sensitivity of skin biopsies in Sneddon's syndrome: a report of 15 cases. Br J Dermatol 2001;145:285 [PubMed]